Over half of American adults are eligible for semaglutide, but insurance and other barriers make it hard for people to access ...

Musk's plan to cut $2 trillion in federal spending could clash with his proposal to subsidize a drug costing up to $1,000 a ...

Struggles with obesity are a longstanding issue for millions of Americans and thousands of Iowans, but recent advancements in ...

With the Biden administration pushing for Medicare, Medicaid coverage of GLP-1s, analysts disagree on whether it will ...

With so many weight loss medications on the market, it's easy to feel overwhelmed by the options. From brand-name heavy ...

A new analysis estimates that losing as little as 5% weight can lead to substantial savings in health care costs elsewhere.

Data suggests that dramatic weight loss, including via GLP-1 drugs, could save Americans big bucks in healthcare spending.

GoodRx's latest research shows surging demand for weight loss medications like Wegovy and Zepbound, despite high costs and ...

The data could be useful as the federal government ponders Medicare coverage for GLP-1 weight loss drugs Savings were ...

A proposal from the Biden administration to provide coverage of weight loss drugs through Medicaid and Medicare may cost more ...

More than half of Americans qualify for GLP-1 receptor agonist drugs, but many can't afford them. Experts share cheaper ...

People who took Zepbound, Eli Lilly’s weight loss drug, shed more pounds than those on Novo Nordisk’s Wegovy in a clinical ...